Havencrest Capital Management Acquires Majority Stake in Tekton Research

Havencrest Capital Management Acquires ThermoTek, Inc.

October 22, 2020

Medical Devices

Havencrest Capital Management, a Dallas-based healthcare private equity firm, has completed the acquisition of ThermoTek, Inc., a Flower Mound, Texas-based designer and manufacturer of temperature management devices for medical and industrial end markets. Havencrest plans to support ThermoTek's growth by expanding its product portfolio, entering adjacent markets and pursuing complementary acquisitions, with Oxford Finance providing debt financing.

Headlands Research Acquires Clinvest Research

May 4, 2023

Healthcare Services

Headlands Research, a multinational clinical trial site network, has acquired Clinvest Research, a Springfield, Missouri-based clinical research site that has conducted over 600 trials since 1996. The deal expands Headlands' chronic pain and endocrinology capabilities and increases participant access for trials in the United States.

Havencrest Capital Management Invests in Paradigm Health

July 7, 2021

Healthcare Services

Dallas-based private equity firm Havencrest Capital Management announced an investment in Paradigm Health, a hospice and palliative care provider headquartered in Indianapolis. The partnership will support Paradigm's growth and geographic expansion across Indiana, with Havencrest partnering alongside the company's founder and management; financial terms were not disclosed.

Havencrest Capital Management Majority Recapitalizes Focus Staff Services

November 2, 2023

Healthcare Services

Dallas-based healthcare private equity firm Havencrest Capital Management completed a majority recapitalization of Focus Staff Services, a Dallas-headquartered provider of nurse and allied temporary staffing across all 50 states. Havencrest will support Focus's growth and has added industry veterans to Focus's board of advisors to help scale the company's workforce solutions for hospitals and integrated delivery networks.

Trinity Hunt Partners Makes Majority Investment in Centricity Research

May 31, 2023

Healthcare Services

Trinity Hunt Partners has made a majority investment in Centricity Research, a North American integrated clinical research organization that conducts Phase I–IV trials across over 40 therapeutic areas. Trinity Hunt said it will partner with Centricity’s management to invest in organic growth and acquire complementary clinical research site businesses to expand capabilities and therapeutic coverage across the U.S. and Canada.

Kohlberg Acquires Majority Stake in Worldwide Clinical Trials

August 7, 2023

Healthcare Services

An affiliate of Kohlberg & Company agreed to acquire a majority stake in Worldwide Clinical Trials, a global contract research organization (CRO) headquartered in Research Triangle Park, North Carolina. The transaction is a recapitalization in which prior investor TJC, L.P. retains a meaningful minority equity stake; terms were not disclosed. Kohlberg will partner with Worldwide's management (Matt Jennings to become chairman) to support continued growth of the company's clinical trial and bioanalytical capabilities.